LATEST NEWS
Study finds immune-based treatment effective against some breast cancers; Former FDA commissioners advocate the agency should be independent; Philip Morris’ new ad urges users to quit smoking
CEO Michael Roth praised IPG’s performance in healthcare in Q3 as helping to lead U.S. growth.
FDA considers banning vape sales in convenience stores; AbbVie settles Humira biosimilar patent dispute; 71% of voters say healthcare is most important midterm issue.
The October 2018 digital edition includes MM&M’s annual Career and Salary Survey, pipeline watch, and the pro ad report for the first half of 2018.
Takeda-Shire merger receives Japanese approval; Publicis Groupe said to be divesting Publicis Health Services; Anthem and HealthCore launch type 2 diabetes study
New research on what attracts patients to volunteer for clinical trials was presented at Digital Pharma East in Philadelphia. The windup: be transparent.
The holding company reported organic growth of 1.3% in the third quarter, but said the Publicis Health Services business dragged down its growth.
Facebook Health’s Danielle Salowski and Merck’s Nancy Nolan shared best practices for Instagram at Digital Pharma East in Philadelphia.
PhRMA pushed back on the HHS plan for disclosing drug prices in ads, putting itself in Trump’s Twitter crosshairs, but experts say flaws in the plan could impede its rollout anyway.
Merck hires Nike exec as chief information, digital officer; Minnesota sues three insulin makers over pricing; UnitedHealth Q3 beats expectations.
